Details of the Drug Formulations

General Information of Drug (ID: DMKVWGE)

• Drug Name: Dexbrompheniramine Drug Info
• Synonyms: Dexbromfeniramina; Dexbrompheniraminum; Ilvin; Parabromodylamine; D-Brompheniramine; Dexbromfeniramina [INN-Spanish]; Dexbrompheniramine [INN:BAN]; Dexbrompheniraminum [INN-Latin]; N,N-Dimethyl-(3-(4-bromphenyl)-3-(2-pyridyl)propyl)amin; (3-p-Bromphenyl-3-pyrid-2'-ylpropyl)dimethylamin; (3S)-3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine; (3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine; (S)-(+)-brompheniramine; (S)-brompheniramine

Indication

Disease Entry	ICD 11	Status	REF
Allergic rhinitis	CA08.0	Approved	[1]
Hay fever	CA08.00	Approved	[2]
Seasonal allergic rhinitis	CA08.01	Approved	[1]
Urticaria	EB00-EB05	Approved	[1]
Vasomotor/allergic rhinitis	CA08	Approved	[1]
Pruritus	EC90	Investigative	[1]

• Therapeutic Class: Antihistamines
• Cross-matching ID:
  PubChem CID: 16960
  ChEBI ID: CHEBI:59269
  CAS Number: 132-21-8
  TTD ID: D02WIW
  ACDINA ID: D00186

Full List of Drug Formulations Containing This Drug

Dexbrompheniramine 1 mg tablet

Company	Formulation ID	FDA Description
Carwin Pharmaceutical Associates	F05483	Stearic acid; Sucralose; Magnesium stearate; Mannitol; Xylitol; Silicon dioxide; Cellulose, microcrystalline

Dexbrompheniramine 2 mg tablet

Company	Formulation ID	FDA Description
Poly Pharmaceuticals	F05482	Magnesium stearate; Calcium phosphate, dibasic, dihydrate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline

References

• [1] Dexbrompheniramine FDA Label
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7588).